Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
- 24 January 2025
- journal article
- review article
- Published by Wiley in ChemistrySelect
- Vol. 10 (4)
Abstract
Therapeutic trends involve designing ligands to target proteins in various diseases, but no parallel filters have been established to prioritize pathological proteins within pathogens for optimal inhibition. This study unveils that in order for a protein to serve as an optimal target for therapeutic intervention, it must exhibit five key attributes. It should have a druggable site with a recognized cleft in which a ligand can be fitted with high specificity. It should possess a unique structure, with distinct sequences having low similarity with other non‐targeted proteins. It should be dispensable for the pathogenesis of a disease, and in the case of microbial infection, it must be crucial for the survival of infectious organisms. It should be available in a crystallized 3D structure to enable high‐throughput screening of candidate ligands. It should occupy an accessible localization to provide an easy route for the ligand to reach its target with less effort. The study justifies five rules as essential filters for considering a protein as an ideal therapeutic target for any protein‐mediated dysfunction. When these rules of targeting proteins are found in a protein, eradicating the intended ailment can primarily be enhanced in less time, money, and effort.Keywords
This publication has 348 references indexed in Scilit:
- Discriminating promiscuous from target‐specific autoantibodies in COVID‐19European Journal of Immunology, 2023
- Targeting NF ‐κB in Oncology, an Untapped Therapeutic Potential2023
- Autosomal dominant cutis laxa and critical stenosis of the left main coronary artery in a 21‐year‐old female with an intronic mutation in the elastin geneAmerican Journal of Medical Genetics Part A, 2022
- Efficient coexpression of recombinant human fusion collagen with prolyl 4‐hydroxylase from Bacillus anthracis in Escherichia coliBiotechnology and Applied Biochemistry, 2022
- Cryptococcus gattii polysaccharide capsule: An insight on fungal‐host interactions and vaccine studiesEuropean Journal of Immunology, 2021
- Drug Design of “Undruggable” TargetsChinese Journal of Chemistry, 2019
- Orotidine 5′‐phosphate decarboxylase‐based reusable in situ genetic editing system: Development and application in taxol‐producing Pestalotiopsis microsporaEngineering in Life Sciences, 2015
- Proteins without unique 3D structures: Biotechnological applications of intrinsically unstable/disordered proteinsBiotechnology Journal, 2014
- Connecting Unexplored Protein Crystal Structures to Enzymatic FunctionChemCatChem, 2012
- Supercomplex organization of the mitochondrial respiratory chain and the role of the Coenzyme Q pool: Pathophysiological implicationsBioFactors, 2005